Ibrutinib for patients with rituximab-refractory Waldenstrm's macro globulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial Journal Articles Refereed uri icon

Overview

Authors

  • Authorship

    • DIMOPOULOS MA
    • HEFFNER LT
    • SHUSTIK C
    • GARCIA-SANZ R
    • CORNELL RF
    • DE LARREA CF
    • CASTILLO JJ
    • GRANELL M
    • KYRTSONIS M-C
    • LEBLOND V
    • SYMEONIDIS A
    • TROTMAN J
    • KASTRITIS E
    • SINGH P
    • LI J
    • GRAEF T
    • BILOTTI E
    • TREON S
    • BUSKE C
    • TEDESCHI A
    • MATOUS JRV
    • MACDONALD D
    • A/PROF Constantine Tam
    • TOURNILHAC O
    • MA S
    • ORIOL A

Published in

  • Lancet Oncology

Time

Date/time value

  • 2017

Identity

Digital Object Identifier (DOI)

  • 10.1016/S1470-2045(16)30632-5

Additional Document Info

Parent Title

  • LANCET ONCOLOGY

Volume

  • 18

Issue

  • 2

Publisher

  • Lancet